Find a story
Search Spins
Search titles, summaries, and missing voices across published articles — press releases, announcements, and media coverage.
14 results for “drug discovery”
Jeff Dean and three other Google execs are leaving to launch Discovery Loop, which will seek AI-powered breakthroughs in drug discovery, chip design, and more (Steven Levy/Wired)
Four senior Google executives, including AI pioneer Jeff Dean, have departed to found Discovery Loop, a startup aiming to apply AI to high-impact domains like drug discovery and chip design.
Aug 5, 2026
Google’s Top AI Brains Are Leaving to Launch Discovery Loop
Former Google AI leaders, including Jeff Dean, have launched Discovery Loop, a startup aiming to apply AI across high-impact scientific and engineering domains.
Aug 5, 2026
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
A press release from MindWalk Holdings Corp. (NASDAQ: HYFT) announces its appearance at a major computing event to signal strategic positioning in AI-driven drug discovery, though no specific product launch, clinical validation, or technical milestone is disclosed.
Jul 24, 2026
Investors bet on AI drug discovery despite approval gap - Financial Times
Venture capital and institutional investors are pouring billions into AI-driven drug discovery startups even though no AI-designed molecule has yet received full regulatory approval for human use.
Jul 21, 2026
Sources: OpenAI researcher Miles Wang is leaving the company to launch an AI drug discovery startup, and is in talks to raise $200M at a $2B valuation (Marina Temkin/TechCrunch)
An OpenAI researcher is departing to found an AI drug discovery startup and is reportedly in early-stage fundraising talks for $200M at a $2B valuation.
Jul 15, 2026
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B - TechCrunch
An OpenAI researcher is reportedly in negotiations to found a new AI-driven drug discovery company with a $2 billion valuation before launch, signaling high investor confidence in AI's near-term biomedical impact.
Jul 15, 2026
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
An unconfirmed report claims OpenAI researcher Miles Wang is in early-stage talks to launch an AI drug discovery startup with a $2B valuation, reflecting investor enthusiasm for AI-driven biotech innovation.
Jul 15, 2026
Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Anthropic has announced it is initiating internal drug discovery programs targeting diseases deemed unprofitable by major pharmaceutical companies, positioning itself as a non-commercial actor in biomedical R&D.
Published Jul 4, 2026 · Analyzed Jul 6, 2026
Researchers say Anthropic's Claude Science will boost drug discovery - Northeastern Global News
A Northeastern Global News article reports that researchers claim Anthropic's 'Claude Science' will accelerate drug discovery, though no specific study, data, or named researchers are provided.
Published Jun 30, 2026 · Analyzed Jul 6, 2026
Anthropic launches AI drug discovery program, joining tech giants in betting on healthcare - CNBC
Anthropic announced a new AI drug discovery initiative, positioning itself alongside major tech firms entering healthcare R&D, though no technical details, partnerships, or validation milestones were disclosed.
Published Jun 30, 2026 · Analyzed Jul 6, 2026
How a Google DeepMind Spin-off Hunts Hidden Drug Targets
Isomorphic Labs, a Google DeepMind spin-off, launched its Isomorphic Drug Design Engine (IsoDDE) to improve AI-driven drug discovery by predicting protein-ligand interactions, pocket identification, and binding affinity—addressing limitations of AlphaFold3 in novel target spaces.
Published Jun 11, 2026 · Analyzed Jul 4, 2026
AI/ML in drug discovery: Unlocking the next era of breakthrough medicines - Axios
The article announces AI and machine learning are transforming drug discovery by accelerating timelines, reducing costs, and enabling novel target identification — positioning this as an inflection point for pharmaceutical innovation.
Published Nov 18, 2025 · Analyzed Jul 12, 2026
Google-backed AI drug discovery startup raises $600 million - Reuters
An AI-powered drug discovery startup backed by Google secured $600 million in new funding, signaling investor confidence in AI's role in pharmaceutical R&D.
Published Mar 31, 2025 · Analyzed Jul 4, 2026
Google DeepMind unveils next generation of drug discovery AI model - Reuters
Google DeepMind announced a new AI model designed to accelerate drug discovery, positioning it as a major advancement in computational biology and therapeutic development.
Published May 9, 2024 · Analyzed Jul 4, 2026